drugset / Trial / NCT00901628

Periarticular Multimodal Drug Injections in Total Knee Arthroplasty

NCT00901628

Phase 4 Completed 101 enrolled Seoul National University Hospital
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine whether periarticular multimodal drug injection (PMDI) would provide additional benefits in patients after total knee arthroplasty (TKA) for whom contemporary pain control protocols using the continuous femoral nerve block, intra-venous patient controlled analgesia (IV-PCA)and preemptive oral medications. We hypothesized that PMDI would reduce pain level and consumption of PCA and acute pain rescuer and would provide better functional recovery and patient satisfaction. We also hypothesized that the incidence of side effects and complications of the PMDI would be similar to the No-PMDI.

Timeline

Start
2008-04
Primary completion
2009-03
Completion
2009-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Cefuroxime Small molecule 750 mg Other
Subject Epinephrine Other / unclassified 300 ug Other
Subject Ketorolac Other / unclassified 30 mg Other
Subject Morphine Other / unclassified 10 mg Other
Subject Ropivacaine Other / unclassified 300 mg Other

Indications